中新网佛山3月14日电 (蔡敏婕 付倩怡)淋巴瘤是常见的血液肿瘤之一,但是传统的治疗手段并不能满足所有淋巴瘤患者的治疗需求。佛山复星禅诚医院肿瘤精准诊疗中心肿瘤内科首席专家叶刚14日表示,当下,以CAR-T细胞治疗为代表的新兴治疗手段逐渐走向临床,为血液肿瘤患者带来了新的希望。

叶刚在一场关于肿瘤治疗的研讨会上指出,CAR-T疗法是一种个性化的免疫治疗方法,它通过基因工程技术改造患者的T细胞,使其能够特异性识别并杀伤肿瘤细胞。这种疗法已经在血液肿瘤的治疗中取得了显著的成效,尤其是在治疗复发难治性淋巴瘤方面。

叶刚进一步表示,虽然CAR-T疗法目前主要应用于血液肿瘤,但未来有望拓展到更多肿瘤类型。他强调,这需要科研人员和临床医生的共同努力,不断探索和完善CAR-T疗法的适应症和治疗方案。

此外,叶刚还提到,CAR-T疗法虽然具有巨大的治疗潜力,但也存在一些挑战,比如治疗成本较高、不良反应管理等问题。他建议,政府和医疗机构应该加大对CAR-T疗法的支持力度,加快相关政策的制定和落实,以提高治疗的普及率和可及性。

英文翻译内容:
Title: CAR-T Therapy Offers New Hope for Blood Cancer Patients
Keywords: CAR-T Therapy, Blood Cancer, Cancer Treatment
News content:
CHENGDU, March 14 (Xinhua) — Lymphoma, a common type of blood cancer, has long been a challenge in terms of treatment, as conventional methods often fail to meet the needs of all patients. However, there is now a glimmer of hope on the horizon with the emergence of chimeric antigen receptor T cell (CAR-T) therapy, according to Chief Expert Yi Gang from the Precision Oncology Center of Fosun Taisen Hospital in Foshan.

Speaking at a symposium on cancer treatment, Yi Gang highlighted the potential of CAR-T therapy, a personalized form of immunotherapy that reprograms a patient’s own T cells to specifically target and kill cancer cells. The therapy has shown remarkable results in the treatment of blood cancers, particularly in patients with relapsed or refractory lymphoma.

Yi Gang emphasized that while CAR-T therapy is currently mainly used for blood cancers, it has the potential to expand to other types of cancer in the future. This will require the concerted efforts of researchers and clinicians to explore and refine the indications and treatment protocols for CAR-T therapy.

Moreover, Yi Gang pointed out that despite its therapeutic potential, CAR-T therapy also faces challenges such as high treatment costs and the management of adverse reactions. He suggested that governments and healthcare institutions should increase their support for CAR-T therapy, expediting the formulation and implementation of related policies to enhance its accessibility and affordability.

【来源】http://www.chinanews.com/life/2024/03-14/10180442.shtml

Views: 1

发表回复

您的邮箱地址不会被公开。 必填项已用 * 标注